SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
IMMUNOGEN
(NQNM:IMGN Last Sale: 4.34 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (IMGN : $4.34)
$756,553 million Market Cap at Market Close, July 1, 2022
Employs 170.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

830 Winter Street Research Report Earnings Snapshot - Last 01/30/19
Waltham, MA 02451 Fact Sheet
Phone: (781) 895-0600 Financial Statements
Peer Comparison
Annual Reports

Daniel M. Junius, CEO, Gregory D. Perry, CFO
Develops innovative biopharmaceuticals, primarily for cancer treatment. Secondary sold 7 million shares thru Jefferies at $12, raising $84 million, May 20, 2011. Formed in 1981.
Historical Charts    Technical Analysis
No Historical Data available for IMGN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common IMGN $4.34 $4.34 0 .0 $3.62 $4.35 3,255,996 $3.62 $4.35 174,320,937
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $756,552,867

A1027
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex